News

Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for Targeted Therapies

View more

Nov 21, 2022

FAPI-PET cuts tracer injection wait times by more than two-thirds

View more

Nov 17, 2022

PET brings clarity and precision in cases of high-grade gliomas

View more

Nov 17, 2022

NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit

View more

Nov 17, 2022

¹⁷⁷Lu-PSMA and ²²⁵Ac-PSMA Radionuclide Therapy for mCRPC

View more

Nov 15, 2022

Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003

View more

Nov 15, 2022